StressCovidV1, PascalFrancis, Corpus, bibRecord, 000029

Gender-Specific Effects of an Augmented Written Emotional Disclosure Intervention on Posttraumatic, Depressive, and HIV-Disease-Related Outcomes: A Randomized, Controlled Trial

Identifieur interne : 000029 ( PascalFrancis/Corpus ); précédent : 000028; suivant : 000030

Gender-Specific Effects of an Augmented Written Emotional Disclosure Intervention on Posttraumatic, Depressive, and HIV-Disease-Related Outcomes: A Randomized, Controlled Trial

Auteurs : Gail Ironson ; Jane Leserman ; Joanne Fordiani ; Conall O'Cleirigh ; Rick Stuetzle ; Mary Ann Fletcher ; Neil Schneiderman

Source :

Journal of consulting and clinical psychology [ 0022-006X ] ; 2013.

RBID : Pascal:13-0222457

Descripteurs français

Pascal (Inist)
- Sexe, Ouverture personnelle, Ecriture, Emotion émotivité, Etat dépressif, SIDA, Essai thérapeutique contrôlé, Virus immunodéficience humaine, Traumatisme, Stress, Etat de stress posttraumatique, Genre, Expression des émotions.

English descriptors

KwdEn :
- AIDS, Controlled therapeutic trial, Depression, Emotion emotionality, Emotional expression, Gender, Hand writing, Human immunodeficiency virus, Posttraumatic stress disorder, Self disclosure, Sex, Stress, Trauma.

Abstract

Objective: Trauma histories and symptoms of PTSD occur at very high rates in people with HIV and are associated with poor disease management and accelerated disease progression. The authors of this study examined the efficacy of a brief written trauma disclosure intervention on posttraumatic stress, depression, HIV-related physical symptoms, and biological markers of HIV disease progression. Method: HIV-infected men and women were randomized to four 30-min expressive writing sessions in either a treatment (trauma writing) or an attention control (daily events writing) condition. The disclosure intervention augmented the traditional emotional disclosure paradigm with probes to increase processing by focusing on trauma appraisals, self-worth, and problem solving. Outcomes were assessed at baseline, 1-, 6-, and 12-month follow-up. Results: Hierarchical linear modeling (N = 244, intent-to-treat analyses) revealed no significant treatment effects for the group as a whole. Gender by treatment group interactions were significant such that women in the trauma-writing group had significantly reduced posttraumatic stress disorder (PTSD) symptoms (p = .017), depression (p = .009), and HIV-related symptoms (p = .022) compared with their controls. In contrast, men in the trauma-treatment condition did not improve more than controls on any outcome variables. Unexpectedly, men in the daily-event-writing control group had significantly greater reductions in depression then men in the trauma-writing group. Treatment effects were magnified in women when the analysis was restricted to those with elevated PTSD symptoms at baseline. Conclusions: A brief (4-session) guided written emotional disclosure intervention resulted in significant and meaningful reductions in PTSD, depression, and physical symptoms for women with HIV, but not for men.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

A01	`01`	`1`		`@0 0022-006X`
A02	`01`			`@0 JCLPBC`
A03		`1`		`@0 J. consult. clin. psychol.`
A05				`@2 81`
A06				`@2 2`
A08	`01`	`1`	`ENG`	`@1 Gender-Specific Effects of an Augmented Written Emotional Disclosure Intervention on Posttraumatic, Depressive, and HIV-Disease-Related Outcomes: A Randomized, Controlled Trial`
A09	`01`	`1`	`ENG`	`@1 Behavioral Medicine and Clinical Health Psychology`
A11	`01`	`1`		`@1 IRONSON (Gail)`
A11	`02`	`1`		`@1 LESERMAN (Jane)`
A11	`03`	`1`		`@1 FORDIANI (Joanne)`
A11	`04`	`1`		`@1 O'CLEIRIGH (Conall)`
A11	`05`	`1`		`@1 STUETZLE (Rick)`
A11	`06`	`1`		`@1 FLETCHER (Mary Ann)`
A11	`07`	`1`		`@1 SCHNEIDERMAN (Neil)`
A12	`01`	`1`		`@1 CRISTENSEN (Alan J.) @9 limin.`
A12	`02`	`1`		`@1 NEZU (Arthur M.) @9 limin.`
A14	`01`			`@1 University of Miami @3 USA @Z 1 aut. @Z 5 aut. @Z 6 aut. @Z 7 aut.`
A14	`02`			`@1 University of North Carolina @2 Chapel Hill @3 USA @Z 2 aut.`
A14	`03`			`@1 VA Boston Healthcare System @2 Boston, Massachusetts @3 USA @Z 3 aut.`
A14	`04`			`@1 Boston VA Research Institute @2 Boston, Massachusetts @3 USA @Z 3 aut.`
A14	`05`			`@1 Harvard Medical School, Massachusetts General Hospital @3 USA @Z 4 aut.`
A15	`01`			`@1 Department of Psychology and Internal Medicine, The University of Iowa, E11 Seashore Hall @2 Iowa City, IA 52242-1409 @3 USA @Z 1 aut.`
A15	`02`			`@1 Departments of Psychology, Medicine, and School of Public Health, Drexel University @3 USA @Z 2 aut.`
A20				`@1 284-298`
A21				`@1 2013`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 2283 @5 354000500658880080`
A44				`@0 0000 @1 © 2013 INIST-CNRS. All rights reserved.`
A45				`@0 2 p.3/4`
A47	`01`	`1`		`@0 13-0222457`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 Journal of consulting and clinical psychology`
A66	`01`			`@0 USA`
C01	`01`		`ENG`	@0 Objective: Trauma histories and symptoms of PTSD occur at very high rates in people with HIV and are associated with poor disease management and accelerated disease progression. The authors of this study examined the efficacy of a brief written trauma disclosure intervention on posttraumatic stress, depression, HIV-related physical symptoms, and biological markers of HIV disease progression. Method: HIV-infected men and women were randomized to four 30-min expressive writing sessions in either a treatment (trauma writing) or an attention control (daily events writing) condition. The disclosure intervention augmented the traditional emotional disclosure paradigm with probes to increase processing by focusing on trauma appraisals, self-worth, and problem solving. Outcomes were assessed at baseline, 1-, 6-, and 12-month follow-up. Results: Hierarchical linear modeling (N = 244, intent-to-treat analyses) revealed no significant treatment effects for the group as a whole. Gender by treatment group interactions were significant such that women in the trauma-writing group had significantly reduced posttraumatic stress disorder (PTSD) symptoms (p = .017), depression (p = .009), and HIV-related symptoms (p = .022) compared with their controls. In contrast, men in the trauma-treatment condition did not improve more than controls on any outcome variables. Unexpectedly, men in the daily-event-writing control group had significantly greater reductions in depression then men in the trauma-writing group. Treatment effects were magnified in women when the analysis was restricted to those with elevated PTSD symptoms at baseline. Conclusions: A brief (4-session) guided written emotional disclosure intervention resulted in significant and meaningful reductions in PTSD, depression, and physical symptoms for women with HIV, but not for men.
C02	`01`	`X`		`@0 002B18C07A`
C02	`02`	`X`		`@0 002B05C02D`
C02	`03`	`X`		`@0 002B18C08D`
C02	`04`	`X`		`@0 002B06D01`
C03	`01`	`X`	`FRE`	`@0 Sexe @5 01`
C03	`01`	`X`	`ENG`	`@0 Sex @5 01`
C03	`01`	`X`	`SPA`	`@0 Sexo @5 01`
C03	`02`	`X`	`FRE`	`@0 Ouverture personnelle @5 02`
C03	`02`	`X`	`ENG`	`@0 Self disclosure @5 02`
C03	`02`	`X`	`SPA`	`@0 Apertura personal @5 02`
C03	`03`	`X`	`FRE`	`@0 Ecriture @5 03`
C03	`03`	`X`	`ENG`	`@0 Hand writing @5 03`
C03	`03`	`X`	`SPA`	`@0 Escritura @5 03`
C03	`04`	`X`	`FRE`	`@0 Emotion émotivité @5 04`
C03	`04`	`X`	`ENG`	`@0 Emotion emotionality @5 04`
C03	`04`	`X`	`SPA`	`@0 Emoción emotividad @5 04`
C03	`05`	`X`	`FRE`	`@0 Etat dépressif @5 05`
C03	`05`	`X`	`ENG`	`@0 Depression @5 05`
C03	`05`	`X`	`SPA`	`@0 Estado depresivo @5 05`
C03	`06`	`X`	`FRE`	`@0 SIDA @5 06`
C03	`06`	`X`	`ENG`	`@0 AIDS @5 06`
C03	`06`	`X`	`SPA`	`@0 SIDA @5 06`
C03	`07`	`X`	`FRE`	`@0 Essai thérapeutique contrôlé @5 07`
C03	`07`	`X`	`ENG`	`@0 Controlled therapeutic trial @5 07`
C03	`07`	`X`	`SPA`	`@0 Ensayo terapéutico controlado @5 07`
C03	`08`	`X`	`FRE`	`@0 Virus immunodéficience humaine @2 NW @5 08`
C03	`08`	`X`	`ENG`	`@0 Human immunodeficiency virus @2 NW @5 08`
C03	`08`	`X`	`SPA`	`@0 Human immunodeficiency virus @2 NW @5 08`
C03	`09`	`X`	`FRE`	`@0 Traumatisme @5 09`
C03	`09`	`X`	`ENG`	`@0 Trauma @5 09`
C03	`09`	`X`	`SPA`	`@0 Traumatismo @5 09`
C03	`10`	`X`	`FRE`	`@0 Stress @5 10`
C03	`10`	`X`	`ENG`	`@0 Stress @5 10`
C03	`10`	`X`	`SPA`	`@0 Estrés @5 10`
C03	`11`	`X`	`FRE`	`@0 Etat de stress posttraumatique @2 NM @5 11`
C03	`11`	`X`	`ENG`	`@0 Posttraumatic stress disorder @2 NM @5 11`
C03	`11`	`X`	`SPA`	`@0 Trastorno de estrés posttraumático @2 NM @5 11`
C03	`12`	`X`	`FRE`	`@0 Genre @4 CD @5 96`
C03	`12`	`X`	`ENG`	`@0 Gender @4 CD @5 96`
C03	`12`	`X`	`SPA`	`@0 Género @4 CD @5 96`
C03	`13`	`X`	`FRE`	`@0 Expression des émotions @4 CD @5 97`
C03	`13`	`X`	`ENG`	`@0 Emotional expression @4 CD @5 97`
C03	`13`	`X`	`SPA`	`@0 Expresión de las emociones @4 CD @5 97`
C07	`01`	`X`	`FRE`	`@0 Virose`
C07	`01`	`X`	`ENG`	`@0 Viral disease`
C07	`01`	`X`	`SPA`	`@0 Virosis`
C07	`02`	`X`	`FRE`	`@0 Infection`
C07	`02`	`X`	`ENG`	`@0 Infection`
C07	`02`	`X`	`SPA`	`@0 Infección`
C07	`03`	`X`	`FRE`	`@0 Lentivirus @2 NW`
C07	`03`	`X`	`ENG`	`@0 Lentivirus @2 NW`
C07	`03`	`X`	`SPA`	`@0 Lentivirus @2 NW`
C07	`04`	`X`	`FRE`	`@0 Retroviridae @2 NW`
C07	`04`	`X`	`ENG`	`@0 Retroviridae @2 NW`
C07	`04`	`X`	`SPA`	`@0 Retroviridae @2 NW`
C07	`05`	`X`	`FRE`	`@0 Virus @2 NW`
C07	`05`	`X`	`ENG`	`@0 Virus @2 NW`
C07	`05`	`X`	`SPA`	`@0 Virus @2 NW`
C07	`06`	`X`	`FRE`	`@0 Langage @5 37`
C07	`06`	`X`	`ENG`	`@0 Language @5 37`
C07	`06`	`X`	`SPA`	`@0 Lenguaje @5 37`
C07	`07`	`X`	`FRE`	`@0 Affect affectivité @5 38`
C07	`07`	`X`	`ENG`	`@0 Affect affectivity @5 38`
C07	`07`	`X`	`SPA`	`@0 Afecto afectividad @5 38`
C07	`08`	`X`	`FRE`	`@0 Trouble de l'humeur @5 39`
C07	`08`	`X`	`ENG`	`@0 Mood disorder @5 39`
C07	`08`	`X`	`SPA`	`@0 Trastorno humor @5 39`
C07	`09`	`X`	`FRE`	`@0 Immunodéficit @5 40`
C07	`09`	`X`	`ENG`	`@0 Immune deficiency @5 40`
C07	`09`	`X`	`SPA`	`@0 Inmunodeficiencia @5 40`
C07	`10`	`X`	`FRE`	`@0 Immunopathologie @5 42`
C07	`10`	`X`	`ENG`	`@0 Immunopathology @5 42`
C07	`10`	`X`	`SPA`	`@0 Inmunopatología @5 42`
C07	`11`	`X`	`FRE`	`@0 Trouble anxieux @5 43`
C07	`11`	`X`	`ENG`	`@0 Anxiety disorder @5 43`
C07	`11`	`X`	`SPA`	`@0 Trastorno ansiedad @5 43`
N21				`@1 203`
N44	`01`			`@1 OTO`
N82				`@1 OTO`

Format Inist (serveur)

NO :	PASCAL 13-0222457 INIST
ET :	Gender-Specific Effects of an Augmented Written Emotional Disclosure Intervention on Posttraumatic, Depressive, and HIV-Disease-Related Outcomes: A Randomized, Controlled Trial
AU :	IRONSON (Gail); LESERMAN (Jane); FORDIANI (Joanne); O'CLEIRIGH (Conall); STUETZLE (Rick); FLETCHER (Mary Ann); SCHNEIDERMAN (Neil); CRISTENSEN (Alan J.); NEZU (Arthur M.)
AF :	University of Miami/Etats-Unis (1 aut., 5 aut., 6 aut., 7 aut.); University of North Carolina/Chapel Hill/Etats-Unis (2 aut.); VA Boston Healthcare System/Boston, Massachusetts/Etats-Unis (3 aut.); Boston VA Research Institute/Boston, Massachusetts/Etats-Unis (3 aut.); Harvard Medical School, Massachusetts General Hospital/Etats-Unis (4 aut.); Department of Psychology and Internal Medicine, The University of Iowa, E11 Seashore Hall/Iowa City, IA 52242-1409/Etats-Unis (1 aut.); Departments of Psychology, Medicine, and School of Public Health, Drexel University/Etats-Unis (2 aut.)
DT :	Publication en série; Niveau analytique
SO :	Journal of consulting and clinical psychology; ISSN 0022-006X; Coden JCLPBC; Etats-Unis; Da. 2013; Vol. 81; No. 2; Pp. 284-298; Bibl. 2 p.3/4
LA :	Anglais
EA :	Objective: Trauma histories and symptoms of PTSD occur at very high rates in people with HIV and are associated with poor disease management and accelerated disease progression. The authors of this study examined the efficacy of a brief written trauma disclosure intervention on posttraumatic stress, depression, HIV-related physical symptoms, and biological markers of HIV disease progression. Method: HIV-infected men and women were randomized to four 30-min expressive writing sessions in either a treatment (trauma writing) or an attention control (daily events writing) condition. The disclosure intervention augmented the traditional emotional disclosure paradigm with probes to increase processing by focusing on trauma appraisals, self-worth, and problem solving. Outcomes were assessed at baseline, 1-, 6-, and 12-month follow-up. Results: Hierarchical linear modeling (N = 244, intent-to-treat analyses) revealed no significant treatment effects for the group as a whole. Gender by treatment group interactions were significant such that women in the trauma-writing group had significantly reduced posttraumatic stress disorder (PTSD) symptoms (p = .017), depression (p = .009), and HIV-related symptoms (p = .022) compared with their controls. In contrast, men in the trauma-treatment condition did not improve more than controls on any outcome variables. Unexpectedly, men in the daily-event-writing control group had significantly greater reductions in depression then men in the trauma-writing group. Treatment effects were magnified in women when the analysis was restricted to those with elevated PTSD symptoms at baseline. Conclusions: A brief (4-session) guided written emotional disclosure intervention resulted in significant and meaningful reductions in PTSD, depression, and physical symptoms for women with HIV, but not for men.
CC :	002B18C07A; 002B05C02D; 002B18C08D; 002B06D01
FD :	Sexe; Ouverture personnelle; Ecriture; Emotion émotivité; Etat dépressif; SIDA; Essai thérapeutique contrôlé; Virus immunodéficience humaine; Traumatisme; Stress; Etat de stress posttraumatique; Genre; Expression des émotions
FG :	Virose; Infection; Lentivirus; Retroviridae; Virus; Langage; Affect affectivité; Trouble de l'humeur; Immunodéficit; Immunopathologie; Trouble anxieux
ED :	Sex; Self disclosure; Hand writing; Emotion emotionality; Depression; AIDS; Controlled therapeutic trial; Human immunodeficiency virus; Trauma; Stress; Posttraumatic stress disorder; Gender; Emotional expression
EG :	Viral disease; Infection; Lentivirus; Retroviridae; Virus; Language; Affect affectivity; Mood disorder; Immune deficiency; Immunopathology; Anxiety disorder
SD :	Sexo; Apertura personal; Escritura; Emoción emotividad; Estado depresivo; SIDA; Ensayo terapéutico controlado; Human immunodeficiency virus; Traumatismo; Estrés; Trastorno de estrés posttraumático; Género; Expresión de las emociones
LO :	INIST-2283.354000500658880080
ID :	13-0222457

Links to Exploration step

Pascal:13-0222457

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Gender-Specific Effects of an Augmented Written Emotional Disclosure Intervention on Posttraumatic, Depressive, and HIV-Disease-Related Outcomes: A Randomized, Controlled Trial</title>
<author><name sortKey="Ironson, Gail" sort="Ironson, Gail" uniqKey="Ironson G" first="Gail" last="Ironson">Gail Ironson</name>
<affiliation><inist:fA14 i1="01"><s1>University of Miami</s1>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Leserman, Jane" sort="Leserman, Jane" uniqKey="Leserman J" first="Jane" last="Leserman">Jane Leserman</name>
<affiliation><inist:fA14 i1="02"><s1>University of North Carolina</s1>
<s2>Chapel Hill</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Fordiani, Joanne" sort="Fordiani, Joanne" uniqKey="Fordiani J" first="Joanne" last="Fordiani">Joanne Fordiani</name>
<affiliation><inist:fA14 i1="03"><s1>VA Boston Healthcare System</s1>
<s2>Boston, Massachusetts</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="04"><s1>Boston VA Research Institute</s1>
<s2>Boston, Massachusetts</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="O Cleirigh, Conall" sort="O Cleirigh, Conall" uniqKey="O Cleirigh C" first="Conall" last="O'Cleirigh">Conall O'Cleirigh</name>
<affiliation><inist:fA14 i1="05"><s1>Harvard Medical School, Massachusetts General Hospital</s1>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Stuetzle, Rick" sort="Stuetzle, Rick" uniqKey="Stuetzle R" first="Rick" last="Stuetzle">Rick Stuetzle</name>
<affiliation><inist:fA14 i1="01"><s1>University of Miami</s1>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Fletcher, Mary Ann" sort="Fletcher, Mary Ann" uniqKey="Fletcher M" first="Mary Ann" last="Fletcher">Mary Ann Fletcher</name>
<affiliation><inist:fA14 i1="01"><s1>University of Miami</s1>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Schneiderman, Neil" sort="Schneiderman, Neil" uniqKey="Schneiderman N" first="Neil" last="Schneiderman">Neil Schneiderman</name>
<affiliation><inist:fA14 i1="01"><s1>University of Miami</s1>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">13-0222457</idno>
<date when="2013">2013</date>
<idno type="stanalyst">PASCAL 13-0222457 INIST</idno>
<idno type="RBID">Pascal:13-0222457</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000029</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Gender-Specific Effects of an Augmented Written Emotional Disclosure Intervention on Posttraumatic, Depressive, and HIV-Disease-Related Outcomes: A Randomized, Controlled Trial</title>
<author><name sortKey="Ironson, Gail" sort="Ironson, Gail" uniqKey="Ironson G" first="Gail" last="Ironson">Gail Ironson</name>
<affiliation><inist:fA14 i1="01"><s1>University of Miami</s1>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Leserman, Jane" sort="Leserman, Jane" uniqKey="Leserman J" first="Jane" last="Leserman">Jane Leserman</name>
<affiliation><inist:fA14 i1="02"><s1>University of North Carolina</s1>
<s2>Chapel Hill</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Fordiani, Joanne" sort="Fordiani, Joanne" uniqKey="Fordiani J" first="Joanne" last="Fordiani">Joanne Fordiani</name>
<affiliation><inist:fA14 i1="03"><s1>VA Boston Healthcare System</s1>
<s2>Boston, Massachusetts</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="04"><s1>Boston VA Research Institute</s1>
<s2>Boston, Massachusetts</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="O Cleirigh, Conall" sort="O Cleirigh, Conall" uniqKey="O Cleirigh C" first="Conall" last="O'Cleirigh">Conall O'Cleirigh</name>
<affiliation><inist:fA14 i1="05"><s1>Harvard Medical School, Massachusetts General Hospital</s1>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Stuetzle, Rick" sort="Stuetzle, Rick" uniqKey="Stuetzle R" first="Rick" last="Stuetzle">Rick Stuetzle</name>
<affiliation><inist:fA14 i1="01"><s1>University of Miami</s1>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Fletcher, Mary Ann" sort="Fletcher, Mary Ann" uniqKey="Fletcher M" first="Mary Ann" last="Fletcher">Mary Ann Fletcher</name>
<affiliation><inist:fA14 i1="01"><s1>University of Miami</s1>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Schneiderman, Neil" sort="Schneiderman, Neil" uniqKey="Schneiderman N" first="Neil" last="Schneiderman">Neil Schneiderman</name>
<affiliation><inist:fA14 i1="01"><s1>University of Miami</s1>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Journal of consulting and clinical psychology</title>
<title level="j" type="abbreviated">J. consult. clin. psychol.</title>
<idno type="ISSN">0022-006X</idno>
<imprint><date when="2013">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Journal of consulting and clinical psychology</title>
<title level="j" type="abbreviated">J. consult. clin. psychol.</title>
<idno type="ISSN">0022-006X</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>AIDS</term>
<term>Controlled therapeutic trial</term>
<term>Depression</term>
<term>Emotion emotionality</term>
<term>Emotional expression</term>
<term>Gender</term>
<term>Hand writing</term>
<term>Human immunodeficiency virus</term>
<term>Posttraumatic stress disorder</term>
<term>Self disclosure</term>
<term>Sex</term>
<term>Stress</term>
<term>Trauma</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Sexe</term>
<term>Ouverture personnelle</term>
<term>Ecriture</term>
<term>Emotion émotivité</term>
<term>Etat dépressif</term>
<term>SIDA</term>
<term>Essai thérapeutique contrôlé</term>
<term>Virus immunodéficience humaine</term>
<term>Traumatisme</term>
<term>Stress</term>
<term>Etat de stress posttraumatique</term>
<term>Genre</term>
<term>Expression des émotions</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Objective: Trauma histories and symptoms of PTSD occur at very high rates in people with HIV and are associated with poor disease management and accelerated disease progression. The authors of this study examined the efficacy of a brief written trauma disclosure intervention on posttraumatic stress, depression, HIV-related physical symptoms, and biological markers of HIV disease progression. Method: HIV-infected men and women were randomized to four 30-min expressive writing sessions in either a treatment (trauma writing) or an attention control (daily events writing) condition. The disclosure intervention augmented the traditional emotional disclosure paradigm with probes to increase processing by focusing on trauma appraisals, self-worth, and problem solving. Outcomes were assessed at baseline, 1-, 6-, and 12-month follow-up. Results: Hierarchical linear modeling (N = 244, intent-to-treat analyses) revealed no significant treatment effects for the group as a whole. Gender by treatment group interactions were significant such that women in the trauma-writing group had significantly reduced posttraumatic stress disorder (PTSD) symptoms (p = .017), depression (p = .009), and HIV-related symptoms (p = .022) compared with their controls. In contrast, men in the trauma-treatment condition did not improve more than controls on any outcome variables. Unexpectedly, men in the daily-event-writing control group had significantly greater reductions in depression then men in the trauma-writing group. Treatment effects were magnified in women when the analysis was restricted to those with elevated PTSD symptoms at baseline. Conclusions: A brief (4-session) guided written emotional disclosure intervention resulted in significant and meaningful reductions in PTSD, depression, and physical symptoms for women with HIV, but not for men.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0022-006X</s0>
</fA01>
<fA02 i1="01"><s0>JCLPBC</s0>
</fA02>
<fA03 i2="1"><s0>J. consult. clin. psychol.</s0>
</fA03>
<fA05><s2>81</s2>
</fA05>
<fA06><s2>2</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Gender-Specific Effects of an Augmented Written Emotional Disclosure Intervention on Posttraumatic, Depressive, and HIV-Disease-Related Outcomes: A Randomized, Controlled Trial</s1>
</fA08>
<fA09 i1="01" i2="1" l="ENG"><s1>Behavioral Medicine and Clinical Health Psychology</s1>
</fA09>
<fA11 i1="01" i2="1"><s1>IRONSON (Gail)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>LESERMAN (Jane)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>FORDIANI (Joanne)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>O'CLEIRIGH (Conall)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>STUETZLE (Rick)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>FLETCHER (Mary Ann)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>SCHNEIDERMAN (Neil)</s1>
</fA11>
<fA12 i1="01" i2="1"><s1>CRISTENSEN (Alan J.)</s1>
<s9>limin.</s9>
</fA12>
<fA12 i1="02" i2="1"><s1>NEZU (Arthur M.)</s1>
<s9>limin.</s9>
</fA12>
<fA14 i1="01"><s1>University of Miami</s1>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>University of North Carolina</s1>
<s2>Chapel Hill</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>VA Boston Healthcare System</s1>
<s2>Boston, Massachusetts</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>Boston VA Research Institute</s1>
<s2>Boston, Massachusetts</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="05"><s1>Harvard Medical School, Massachusetts General Hospital</s1>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</fA14>
<fA15 i1="01"><s1>Department of Psychology and Internal Medicine, The University of Iowa, E11 Seashore Hall</s1>
<s2>Iowa City, IA 52242-1409</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</fA15>
<fA15 i1="02"><s1>Departments of Psychology, Medicine, and School of Public Health, Drexel University</s1>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</fA15>
<fA20><s1>284-298</s1>
</fA20>
<fA21><s1>2013</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>2283</s2>
<s5>354000500658880080</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2013 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>2 p.3/4</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>13-0222457</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Journal of consulting and clinical psychology</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>Objective: Trauma histories and symptoms of PTSD occur at very high rates in people with HIV and are associated with poor disease management and accelerated disease progression. The authors of this study examined the efficacy of a brief written trauma disclosure intervention on posttraumatic stress, depression, HIV-related physical symptoms, and biological markers of HIV disease progression. Method: HIV-infected men and women were randomized to four 30-min expressive writing sessions in either a treatment (trauma writing) or an attention control (daily events writing) condition. The disclosure intervention augmented the traditional emotional disclosure paradigm with probes to increase processing by focusing on trauma appraisals, self-worth, and problem solving. Outcomes were assessed at baseline, 1-, 6-, and 12-month follow-up. Results: Hierarchical linear modeling (N = 244, intent-to-treat analyses) revealed no significant treatment effects for the group as a whole. Gender by treatment group interactions were significant such that women in the trauma-writing group had significantly reduced posttraumatic stress disorder (PTSD) symptoms (p = .017), depression (p = .009), and HIV-related symptoms (p = .022) compared with their controls. In contrast, men in the trauma-treatment condition did not improve more than controls on any outcome variables. Unexpectedly, men in the daily-event-writing control group had significantly greater reductions in depression then men in the trauma-writing group. Treatment effects were magnified in women when the analysis was restricted to those with elevated PTSD symptoms at baseline. Conclusions: A brief (4-session) guided written emotional disclosure intervention resulted in significant and meaningful reductions in PTSD, depression, and physical symptoms for women with HIV, but not for men.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B18C07A</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B05C02D</s0>
</fC02>
<fC02 i1="03" i2="X"><s0>002B18C08D</s0>
</fC02>
<fC02 i1="04" i2="X"><s0>002B06D01</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Sexe</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Sex</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Sexo</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Ouverture personnelle</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Self disclosure</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Apertura personal</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Ecriture</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Hand writing</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Escritura</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Emotion émotivité</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Emotion emotionality</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Emoción emotividad</s0>
<s5>04</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Etat dépressif</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Depression</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Estado depresivo</s0>
<s5>05</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>SIDA</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>AIDS</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>SIDA</s0>
<s5>06</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Essai thérapeutique contrôlé</s0>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Controlled therapeutic trial</s0>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Ensayo terapéutico controlado</s0>
<s5>07</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Virus immunodéficience humaine</s0>
<s2>NW</s2>
<s5>08</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Human immunodeficiency virus</s0>
<s2>NW</s2>
<s5>08</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Human immunodeficiency virus</s0>
<s2>NW</s2>
<s5>08</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Traumatisme</s0>
<s5>09</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Trauma</s0>
<s5>09</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Traumatismo</s0>
<s5>09</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Stress</s0>
<s5>10</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Stress</s0>
<s5>10</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Estrés</s0>
<s5>10</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE"><s0>Etat de stress posttraumatique</s0>
<s2>NM</s2>
<s5>11</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG"><s0>Posttraumatic stress disorder</s0>
<s2>NM</s2>
<s5>11</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA"><s0>Trastorno de estrés posttraumático</s0>
<s2>NM</s2>
<s5>11</s5>
</fC03>
<fC03 i1="12" i2="X" l="FRE"><s0>Genre</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC03 i1="12" i2="X" l="ENG"><s0>Gender</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC03 i1="12" i2="X" l="SPA"><s0>Género</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC03 i1="13" i2="X" l="FRE"><s0>Expression des émotions</s0>
<s4>CD</s4>
<s5>97</s5>
</fC03>
<fC03 i1="13" i2="X" l="ENG"><s0>Emotional expression</s0>
<s4>CD</s4>
<s5>97</s5>
</fC03>
<fC03 i1="13" i2="X" l="SPA"><s0>Expresión de las emociones</s0>
<s4>CD</s4>
<s5>97</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Virose</s0>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Viral disease</s0>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Virosis</s0>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Infection</s0>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Infection</s0>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Infección</s0>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Lentivirus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Lentivirus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Lentivirus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Retroviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Retroviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Retroviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Langage</s0>
<s5>37</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Language</s0>
<s5>37</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Lenguaje</s0>
<s5>37</s5>
</fC07>
<fC07 i1="07" i2="X" l="FRE"><s0>Affect affectivité</s0>
<s5>38</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG"><s0>Affect affectivity</s0>
<s5>38</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA"><s0>Afecto afectividad</s0>
<s5>38</s5>
</fC07>
<fC07 i1="08" i2="X" l="FRE"><s0>Trouble de l'humeur</s0>
<s5>39</s5>
</fC07>
<fC07 i1="08" i2="X" l="ENG"><s0>Mood disorder</s0>
<s5>39</s5>
</fC07>
<fC07 i1="08" i2="X" l="SPA"><s0>Trastorno humor</s0>
<s5>39</s5>
</fC07>
<fC07 i1="09" i2="X" l="FRE"><s0>Immunodéficit</s0>
<s5>40</s5>
</fC07>
<fC07 i1="09" i2="X" l="ENG"><s0>Immune deficiency</s0>
<s5>40</s5>
</fC07>
<fC07 i1="09" i2="X" l="SPA"><s0>Inmunodeficiencia</s0>
<s5>40</s5>
</fC07>
<fC07 i1="10" i2="X" l="FRE"><s0>Immunopathologie</s0>
<s5>42</s5>
</fC07>
<fC07 i1="10" i2="X" l="ENG"><s0>Immunopathology</s0>
<s5>42</s5>
</fC07>
<fC07 i1="10" i2="X" l="SPA"><s0>Inmunopatología</s0>
<s5>42</s5>
</fC07>
<fC07 i1="11" i2="X" l="FRE"><s0>Trouble anxieux</s0>
<s5>43</s5>
</fC07>
<fC07 i1="11" i2="X" l="ENG"><s0>Anxiety disorder</s0>
<s5>43</s5>
</fC07>
<fC07 i1="11" i2="X" l="SPA"><s0>Trastorno ansiedad</s0>
<s5>43</s5>
</fC07>
<fN21><s1>203</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
<server><NO>PASCAL 13-0222457 INIST</NO>
<ET>Gender-Specific Effects of an Augmented Written Emotional Disclosure Intervention on Posttraumatic, Depressive, and HIV-Disease-Related Outcomes: A Randomized, Controlled Trial</ET>
<AU>IRONSON (Gail); LESERMAN (Jane); FORDIANI (Joanne); O'CLEIRIGH (Conall); STUETZLE (Rick); FLETCHER (Mary Ann); SCHNEIDERMAN (Neil); CRISTENSEN (Alan J.); NEZU (Arthur M.)</AU>
<AF>University of Miami/Etats-Unis (1 aut., 5 aut., 6 aut., 7 aut.); University of North Carolina/Chapel Hill/Etats-Unis (2 aut.); VA Boston Healthcare System/Boston, Massachusetts/Etats-Unis (3 aut.); Boston VA Research Institute/Boston, Massachusetts/Etats-Unis (3 aut.); Harvard Medical School, Massachusetts General Hospital/Etats-Unis (4 aut.); Department of Psychology and Internal Medicine, The University of Iowa, E11 Seashore Hall/Iowa City, IA 52242-1409/Etats-Unis (1 aut.); Departments of Psychology, Medicine, and School of Public Health, Drexel University/Etats-Unis (2 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Journal of consulting and clinical psychology; ISSN 0022-006X; Coden JCLPBC; Etats-Unis; Da. 2013; Vol. 81; No. 2; Pp. 284-298; Bibl. 2 p.3/4</SO>
<LA>Anglais</LA>
<EA>Objective: Trauma histories and symptoms of PTSD occur at very high rates in people with HIV and are associated with poor disease management and accelerated disease progression. The authors of this study examined the efficacy of a brief written trauma disclosure intervention on posttraumatic stress, depression, HIV-related physical symptoms, and biological markers of HIV disease progression. Method: HIV-infected men and women were randomized to four 30-min expressive writing sessions in either a treatment (trauma writing) or an attention control (daily events writing) condition. The disclosure intervention augmented the traditional emotional disclosure paradigm with probes to increase processing by focusing on trauma appraisals, self-worth, and problem solving. Outcomes were assessed at baseline, 1-, 6-, and 12-month follow-up. Results: Hierarchical linear modeling (N = 244, intent-to-treat analyses) revealed no significant treatment effects for the group as a whole. Gender by treatment group interactions were significant such that women in the trauma-writing group had significantly reduced posttraumatic stress disorder (PTSD) symptoms (p = .017), depression (p = .009), and HIV-related symptoms (p = .022) compared with their controls. In contrast, men in the trauma-treatment condition did not improve more than controls on any outcome variables. Unexpectedly, men in the daily-event-writing control group had significantly greater reductions in depression then men in the trauma-writing group. Treatment effects were magnified in women when the analysis was restricted to those with elevated PTSD symptoms at baseline. Conclusions: A brief (4-session) guided written emotional disclosure intervention resulted in significant and meaningful reductions in PTSD, depression, and physical symptoms for women with HIV, but not for men.</EA>
<CC>002B18C07A; 002B05C02D; 002B18C08D; 002B06D01</CC>
<FD>Sexe; Ouverture personnelle; Ecriture; Emotion émotivité; Etat dépressif; SIDA; Essai thérapeutique contrôlé; Virus immunodéficience humaine; Traumatisme; Stress; Etat de stress posttraumatique; Genre; Expression des émotions</FD>
<FG>Virose; Infection; Lentivirus; Retroviridae; Virus; Langage; Affect affectivité; Trouble de l'humeur; Immunodéficit; Immunopathologie; Trouble anxieux</FG>
<ED>Sex; Self disclosure; Hand writing; Emotion emotionality; Depression; AIDS; Controlled therapeutic trial; Human immunodeficiency virus; Trauma; Stress; Posttraumatic stress disorder; Gender; Emotional expression</ED>
<EG>Viral disease; Infection; Lentivirus; Retroviridae; Virus; Language; Affect affectivity; Mood disorder; Immune deficiency; Immunopathology; Anxiety disorder</EG>
<SD>Sexo; Apertura personal; Escritura; Emoción emotividad; Estado depresivo; SIDA; Ensayo terapéutico controlado; Human immunodeficiency virus; Traumatismo; Estrés; Trastorno de estrés posttraumático; Género; Expresión de las emociones</SD>
<LO>INIST-2283.354000500658880080</LO>
<ID>13-0222457</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/StressCovidV1/Data/PascalFrancis/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000029 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000029 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    StressCovidV1
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:13-0222457
   |texte=   Gender-Specific Effects of an Augmented Written Emotional Disclosure Intervention on Posttraumatic, Depressive, and HIV-Disease-Related Outcomes: A Randomized, Controlled Trial
}}

This area was generated with Dilib version V0.6.33.
Data generation: Wed May 6 16:44:09 2020. Site generation: Sun Mar 28 08:26:57 2021

	Serveur d'exploration Stress et Covid
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration Stress et Covid

Gender-Specific Effects of an Augmented Written Emotional Disclosure Intervention on Posttraumatic, Depressive, and HIV-Disease-Related Outcomes: A Randomized, Controlled Trial

Gender-Specific Effects of an Augmented Written Emotional Disclosure Intervention on Posttraumatic, Depressive, and HIV-Disease-Related Outcomes: A Randomized, Controlled Trial

Source :

Descripteurs français

English descriptors

Abstract

Notice en format standard (ISO 2709)

Format Inist (serveur)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri